DocGo Inc. Legal Fees
DocGo Inc. (DCGO) reported Legal Fees of $4.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2026-08-17
- DocGo Inc. legal fees for the quarter ending 2026-06-30 was $4.03M, a 7.50% decline year-over-year.
- DocGo Inc. legal fees for the quarter ending 2026-03-31 was $5.03M, a 19.55% increase year-over-year.
- DocGo Inc. legal fees for the quarter ending 2025-12-31 was $9.53M, a 72.51% increase year-over-year.
- DocGo Inc. legal fees for the quarter ending 2025-09-30 was $5.73M, a 73.80% increase year-over-year.
- DocGo Inc. legal fees for fiscal 2025 was $23.82M, a 38.92% increase from fiscal 2024.
- DocGo Inc. legal fees for fiscal 2024 was $17.15M, a 31.07% increase from fiscal 2023.
- DocGo Inc. legal fees for fiscal 2023 was $13.08M, a 48.99% increase from fiscal 2022.
- DocGo Inc. legal fees for fiscal 2022 was $8.78M, a 124.70% increase from fiscal 2021.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.03M 10-Q · filed 2026-08-17 | $9.06M 10-Q · filed 2026-08-17 | $18.59M derived: sum of 3 quarters · filed 2026-08-17 | $24.32M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $5.03M 10-Q · filed 2026-05-11 | $14.56M derived: sum of 2 quarters · filed 2026-05-11 | $20.29M derived: sum of 3 quarters · filed 2026-05-11 | $24.64M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $9.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $15.26M derived: sum of 2 quarters · filed 2026-03-16 | $19.61M derived: sum of 3 quarters · filed 2026-08-17 | $23.82M 10-K · filed 2026-03-16 |
| 2025-09-30 | $5.73M 10-Q · filed 2025-11-10 | $10.08M derived: sum of 2 quarters · filed 2026-08-17 | $14.29M 10-Q · filed 2025-11-10 | $19.81M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $4.35M 10-Q · filed 2026-08-17 | $8.56M 10-Q · filed 2026-08-17 | $14.09M derived: sum of 3 quarters · filed 2026-08-17 | $17.38M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $4.21M 10-Q · filed 2026-05-11 | $9.74M derived: sum of 2 quarters · filed 2026-05-11 | $13.03M derived: sum of 3 quarters · filed 2026-05-11 | $17.04M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $8.82M derived: sum of 2 quarters · filed 2026-03-16 | $12.83M derived: sum of 3 quarters · filed 2026-03-16 | $17.15M 10-K · filed 2026-03-16 |
| 2024-09-30 | $3.30M 10-Q · filed 2025-11-10 | $7.31M derived: sum of 2 quarters · filed 2025-11-10 | $11.62M 10-Q · filed 2025-11-10 | $15.12M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $4.01M 10-Q · filed 2025-08-07 | $8.33M 10-Q · filed 2025-08-07 | $11.82M derived: sum of 3 quarters · filed 2026-03-16 | $15.37M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $4.31M 10-Q · filed 2025-05-08 | $7.81M derived: sum of 2 quarters · filed 2026-03-16 | $11.35M derived: sum of 3 quarters · filed 2026-03-16 | $13.76M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $7.04M derived: sum of 2 quarters · filed 2026-03-16 | $9.44M derived: sum of 3 quarters · filed 2026-03-16 | $13.08M 10-K · filed 2026-03-16 |
| 2023-09-30 | $3.55M 10-Q · filed 2024-11-07 | $5.95M derived: sum of 2 quarters · filed 2024-11-07 | $9.59M 10-Q · filed 2024-11-07 | $11.76M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.40M 10-Q · filed 2024-08-07 | $6.04M 10-Q · filed 2024-08-07 | $8.21M derived: sum of 3 quarters · filed 2025-02-27 | $10.41M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.64M 10-Q · filed 2024-05-08 | $5.81M derived: sum of 2 quarters · filed 2025-02-27 | $8.01M derived: sum of 3 quarters · filed 2025-02-27 | $11.07M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.37M derived: sum of 2 quarters · filed 2025-02-27 | $7.43M derived: sum of 3 quarters · filed 2025-02-27 | $8.78M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.20M 10-Q · filed 2023-11-06 | $5.26M derived: sum of 2 quarters · filed 2023-11-06 | $6.61M 10-Q · filed 2023-11-06 | $7.87M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $3.06M 10-Q · filed 2023-08-08 | $4.41M 10-Q · filed 2023-08-08 | $5.67M derived: sum of 3 quarters · filed 2024-02-28 | $6.48M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.35M 10-Q · filed 2023-05-09 | $2.61M derived: sum of 2 quarters · filed 2024-02-28 | $3.42M derived: sum of 3 quarters · filed 2024-02-28 | $4.60M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.07M derived: sum of 2 quarters · filed 2024-02-28 | $3.25M derived: sum of 3 quarters · filed 2024-02-28 | $3.91M 10-K · filed 2024-02-28 |
| 2021-09-30 | $813.20K 10-Q · filed 2022-11-08 | $1.99M derived: sum of 2 quarters · filed 2022-11-08 | $2.65M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.18M 10-Q · filed 2022-08-09 | $1.83M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $656.66K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $3.75M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |